Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 1754Urinary Bladder Neoplasms 351Carcinoma, Renal Cell 217Breast Neoplasms 210Neoplasms 164Kidney Neoplasms 158Lung Neoplasms 101Colorectal Neoplasms 95Motor Activity 85Testicular Neoplasms 60Ovarian Neoplasms 53Colonic Neoplasms 48Melanoma 47Pancreatic Neoplasms 44Neoplasm Metastasis 43Non-Muscle Invasive Bladder Neoplasms 42Urinary Incontinence 40Head and Neck Neoplasms 40Carcinoma, Transitional Cell 40Uterine Cervical Neoplasms 39Disease 39Sarcoma 37Urologic Neoplasms 36Recurrence 35Anxiety Disorders 32Stomach Neoplasms 29Carcinoma, Non-Small-Cell Lung 29Lymphoma 28Endometrial Neoplasms 28Prostatic Hyperplasia 27

Interventions

Sodium Chloride 1Lidocaine 1Hyperthermic Intraperitoneal Chemotherapy 1Cystectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Invasive Bladder Cancer × Genitourinary × Clear all
NCT03514888 2023-08-28

HIPEC After Radical Cystectomy for High Risk Bladder Cancer

Weill Medical College of Cornell University

Phase NA Completed
7 enrolled
Genitourinary

Invasive Bladder Cancer

NCT02924480 2022-03-09

Lidocaine

CAMC Health System

Phase NA Completed
50 enrolled
Genitourinary

Invasive Bladder Cancer

NCT03862105 2020-06-12

Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
33 enrolled
Genitourinary

Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡